Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis

• Autorzy: Goldust M. , Rezaee E. , Masoudnia S. , Raghifar R.
• Języki publikacji: EN

Abstrakty

EN

Seborrheic dermatitis (SD) is an inflammatory skin disorder affecting the scalp, face, and trunk, however, there are controversies surrounding its treatment. The aim of the study is to compare the efficacy of sertaconazole 2% cream with hydrocortisone 1% cream in the treatment of seborrheic dermatitis. In total, 138 patients suffering from seborrheic dermatitis were studied. Sixty-nine patients received local sertoconazole 2% cream and they were recommended to use the cream twice a day and for 4 weeks. To create a control group, 69 patients received hydrocortisone 1% cream twice a day for four weeks. At the time of referral, and at 2 and 4 weeks after their first visit, the patients were examined by a dermatologist to check the improvement of clinical symptoms. The mean age of patients was 36.45±13.23. The highest level of satisfaction (85.1%) was observed 28 days after sertaconazole consumption: 76.9% was recorded for the hydrocortisone group. No relapse of the disease one month after stopping treatment was observed in either the sertaconazole 2% group or the hydrocortisone 1% group. Sertaconazole 2% cream may be an excellent alternative therapeutic modality for treating seborrheic dermatitis.

Słowa kluczowe

EN

sertaconazole; cream; hydrocortisone; treatment; seborrheic dermatitis; dermatitis; skin disorder; human disease; patient

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2013
• Tom: 59
• Numer: 3
• Opis fizyczny: p.119-123,ref.

Twórcy

autor

Goldust M.

• Student Research Committee, Tabriz University of Medical Sciences, Iran

autor

Rezaee E.

• Department of Medicinal Chemistry, Shahid Beheshti University of Medical Sciences, Teheran, Iran

autor

Masoudnia S.

• Student Research Committee, Tabriz University of Medical Sciences, Iran

autor

Raghifar R.

• Student Research Committee, Tabriz University of Medical Sciences, Iran

Bibliografia

• [1] Aschoff R., Kempter W., Meurer M. 2011. Seborrheic dermatitis. Hautarzt: 62: 297-307.
• [2] Goldust M., Rezaee E. 2013. The efficacy of topical ivermectin vs. malation 0.5% lotion for the treatment of scabies. Journal of Dermatological Treatment doi: 10.3109/09546634.2013.782093.
• [3] Schwartz J.L., Clinton T.S. 2011. Darier’s disease misdiagnosed as severe seborrheic dermatitis. Military Medicine 176: 1457-1459.
• [4] Lotti T., Goldust M., Rezaee E. 2013. Treatment of seborrheic dermatitis: Comparison of sertaconazole 2 % cream vs. ketoconazole 2% cream. Journal of Dermatological Treatment doi:10.3109/09546634.2013.777154.
• [5] Goldust M., Rezaee E., Raghifar R. 2013. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutaneous and Ocular Toxicology doi: 10.3109/15569527. 2013.768258.
• [6] Mohebbipour A., Saleh P., Goldust M., Amirnia M., Zadeh Y.J., Mohamadi R.M., Rezaee E. 2012. Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%. Acta Dermatovenerologica Croatica 20: 251-255.
• [7] Stefanaki I., Katsambas A. 2010. Therapeutic update on seborrheic dermatitis. Skin Therapy Letter 15: 1-4.
• [8] Goldust M., Talebi M., Majidi J., Saatlou M.A.R., Rezaee E.. 2013. Evaluation of antiphospholipid antibodies in youths suffering from cerebral ischemia. International Journal of Neuroscience 123: 209-212.
• [9] Kim K.S., Shin M.K., Ahn J.J., Haw C.R., Park H.K. 2013. A comparative study of hair shafts in scalp psoriasis and seborrheic dermatitis using atomic force microscopy. Skin Research and Technology 19: 60-64.
• [10] Goldust M., Ranjkesh M.R., Amirinia M., Golforoushan F., Rezaee E., Rezazadeh Saatlou M.A. 2013. Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. Journal of Dermatological Treatment doi: 10.3109/09546634.2012.755251.
• [11] Berk T., Scheinfeld N. 2010. Seborrheic dermatitis. Pharmacy and Terapeutics 35: 348-352.
• [12] Goldust M., Babae N.S., Rezaee E., Raghifar R. 2013. Comparative trial of permethrin 5% versus lindane 1% for the treatment of scabies. Journal of Dermatological Treatment doi: 10.3109/09546634.2012.723122.
• [13] Breunig J.A., de Almeida H.L.J., Duquia R.P et al. 2012. Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents. International Journal of Dermatology 51: 46-49.
• [14] Goldust M., Rezaee E., Hemayat S. 2012. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. Journal of Dermatology 39: 545-547.
• [15] Ang-Tiu C.U., Meghrajani C.F., Maano C.C. 2012. Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Review of Clinical Pharmacology 5: 91-97.
• [16] Zhang R., Zhu W. 2011. Coexistence of dermatosis neglecta, facial seborrheic dermatitis, and corticosteroid-dependent dermatitis in a 21-year-old woman. American Journal of Clinical Dermatology 12: 347-348.
• [17] Treadwell P.A. 2011. Papulosquamous disorders: atopic dermatitis, psoriasis, seborrheic dermatitis, and nickel contact dermatitis. Adolescent medicine: state of the art reviews 22: 157-168.
• [18] Schmidt J.A. 2011. Seborrheic dermatitis: a clinical practice snapshot. Nurse Practicioner 36: 32-37.
• [19] Apasrawirote W., Udompataikul M., Rattanamongkolgul S. 2011. Topical antifungal agents for seborrheic dermatitis: systematic review and metaanalysis. Journal of Medical Association of Thailand 94: 756-760.
• [20] Papp K.A., Papp A., Dahmer B., Clark C.S. 2011. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. Journal of American Academy of Dermatology 67: 11-15.
• [21] Rovelli F., Mercuri S.R., Naldi L. 2011. Seborrheic dermatitis in clinical practice. Recenti Progressi in Medicina 102: 126-133.
• [22] Weinberg J.M., Koestenblatt E.K. 2011. Treatment of interdigital tinea pedis: once-daily therapy with sertaconazole nitrate. Journal of Drugs in Dermatology 10: 1135-1140.
• [23] Croxtall J.D., Plosker G.L. 2009. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs: 69: 339-359.
• [24] Carrillo-Munoz A.J., Tur-Tur C., Cardenes D.C., D.C. Pedisfloccosum. 2011. Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, causative agents of tinea pedis. Antimicrobial Agents and Chemotherapy: 55: 4420-4421.
• [25] Borelli C., Korting H.C., Bodeker R.H. 2010. Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. Cutis 85: 107-111.
• [26] Kircik L.H. 2009. Observational evaluation of sertaconazole nitrate cream 2% in the treatment of pruritus related to tinea pedis. Cutis: 84: 279-283.
• [27] Firooz A., Solhpour A., Gorouhi F. et al. 2006. Pimecrolimus cream, 1% vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Archives of Dermatology 142: 1066-1067.
• [28] Elewski B.E., Cantrell W.C. 2011. An open-label study of the safety and efficacy of sertaconazole nitrate in the treatment of seborrheic dermatitis. Journal of Drugs in Dermatology 2011;10:895-899.